1
|
Keith RL and Miller YE: Lung cancer
chemoprevention: current status and future prospects. Nat Rev Clin
Oncol. 10:334–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
4
|
van Kouwenhove M, Kedde M and Agami R:
MicroRNA regulation by RNA-binding proteins and its implications
for cancer. Nat Rev Cancer. 11:644–656. 2011.PubMed/NCBI
|
5
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar
|
6
|
Nana-Sinkam SP and Croce CM: Clinical
applications for microRNAs in cancer. Clin Pharmacol Ther.
93:98–104. 2013. View Article : Google Scholar
|
7
|
Sittka A and Schmeck B: MicroRNAs in the
lung. Adv Exp Med Biol. 774:121–134. 2013. View Article : Google Scholar
|
8
|
Redova M, Sana J and Slaby O: Circulating
miRNAs as new blood-based biomarkers for solid cancers. Future
Oncol. 9:387–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ma Q, Jiang Q, Pu Q, Zhang X, Yang W, et
al: MicroRNA-143 inhibits migration and invasion of human
non-small-cell lung cancer and its relative mechanism. Int J Biol
Sci. 9:680–692. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk - database: prediction of possible miRNA binding sites by
‘walking’ the genes of 3 genomes. J Biomed Inform. 44:839–847.
2011.
|
11
|
Seigne C, Auret M, Treilleux I, Bonnavion
R, Assade F, et al: High incidence of mammary intraepithelial
neoplasia development in Men1-disrupted murine mammary glands. J
Pathol. 229:546–558. 2013. View Article : Google Scholar
|
12
|
Gang D, Hongwei H, Hedai L, Ming Z, Qian H
and Zhijun L: The tumor suppressor protein menin inhibits
NF-κB-mediated transactivation through recruitment of Sirt1 in
hepatocellular carcinoma. Mol Biol Rep. 40:2461–2466. 2013.
|
13
|
Veniaminova NA, Hayes MM, Varney JM and
Merchant JL: Conditional deletion of menin results in antral G cell
hyperplasia and hypergastrinemia. Am J Physiol Gastrointest Liver
Physiol. 303:G752–G764. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sansom SE, Nuovo GJ, Martin MM, Kotha SR,
Parinandi NL and Elton TS: miR-802 regulates human angiotensin II
type 1 receptor expression in intestinal epithelial C2BBe1 cells.
Am J Physiol Gastrointest Liver Physiol. 299:G632–G642. 2010.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Kornfeld JW, Baitzel C, Könner AC,
Nicholls HT, Vogt MC, et al: Obesity-induced overexpression of
miR-802 impairs glucose metabolism through silencing of Hnf1b.
Nature. 494:111–115. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Gaztambide S, Vazquez F and Castaño L:
Diagnosis and treatment of multiple endocrine neoplasia type 1
(MEN1). Minerva Endocrinol. 38:17–28. 2013.PubMed/NCBI
|
17
|
Matkar S, Thiel A and Hua X: Menin: a
scaffold protein that controls gene expression and cell signaling.
Trends Biochem Sci. 38:394–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Debelenko LV, Brambilla E, Agarwal SK,
Swalwell JI, Kester MB, et al: Identification of MEN1 gene
mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet.
6:2285–2290. 1997. View Article : Google Scholar : PubMed/NCBI
|
19
|
Haruki N, Yatabe Y, Travis WD, Nomoto S,
Osada H, et al: Characterization of high-grade neuroendocrine
tumors of the lung in relation to menin mutations. Jpn J Cancer
Res. 91:317–323. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Gao SB, Feng ZJ, Xu B, Wu Y, Yin P, et al:
Suppression of lung adenocarcinoma through menin and polycomb
gene-mediated repression of growth factor pleiotrophin. Oncogene.
28:4095–4104. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Feng ZJ, Gao SB, Wu Y, Xu XF, Hua X and
Jin GH: Lung cancer cell migration is regulated via repressing
growth factor PTN/RPTP β/ζ signaling by menin. Oncogene.
29:5416–5426. 2010.PubMed/NCBI
|